Clinical Trial Update: Association of BAL Fluid T-Cell Immune Activity With Tumor PD-L1 Expression and Its Prognostic Value: A Prospective Observational Study

View source ↗

Summary

This ClinicalTrials.gov entry describes a prospective observational study in lung cancer to evaluate BAL fluid T-cell activity and its association with tumor PD…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Seoul National University Hospital | Conditions: Lung Neoplasms, Tumor Immune Microenvironment | Status: NOT_YET_RECRUITING